Sanofi to acquire BTK inhibitor firm Principia for $3.7 billion

Friday, August 21, 2020 - 18:51 in Health & Medicine

Principia is testing its small-molecule compounds in multiple sclerosis and immune system diseases

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net